169 related articles for article (PubMed ID: 28182350)
21. Serum microRNA-18a, MicroRNA-21 and microRNA-92a as diagnostic markers in colorectal cancer patients.
Elaguizy M; Sheta M; Ibrahim N; Eltaweel A; Mostafa A
J BUON; 2020; 25(3):1443-1448. PubMed ID: 32862588
[TBL] [Abstract][Full Text] [Related]
22. The expression profiling of serum miR-92a, miR-375, and miR-760 in colorectal cancer: An Egyptian study.
Elshafei A; Shaker O; Abd El-Motaal O; Salman T
Tumour Biol; 2017 Jun; 39(6):1010428317705765. PubMed ID: 28618945
[TBL] [Abstract][Full Text] [Related]
23. A New MicroRNA Expression Signature for Cervical Cancer.
Sun P; Shen Y; Gong JM; Zhou LL; Sheng JH; Duan FJ
Int J Gynecol Cancer; 2017 Feb; 27(2):339-343. PubMed ID: 27870701
[TBL] [Abstract][Full Text] [Related]
24. A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
Qiu H; Liang D; Liu L; Xiang Q; Yi Z; Ji Y
Technol Cancer Res Treat; 2020; 19():1533033820970667. PubMed ID: 33327867
[TBL] [Abstract][Full Text] [Related]
25. Circulating plasma microRNA signature for the diagnosis of cervical cancer.
Ma G; Song G; Zou X; Shan X; Liu Q; Xia T; Zhou X; Zhu W
Cancer Biomark; 2019; 26(4):491-500. PubMed ID: 31658043
[TBL] [Abstract][Full Text] [Related]
26. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.
Liu SS; Chan KKL; Chu DKH; Wei TN; Lau LSK; Ngu SF; Chu MMY; Tse KY; Ip PPC; Ng EKO; Cheung ANY; Ngan HYS
Mol Oncol; 2018 Dec; 12(12):2009-2022. PubMed ID: 30221475
[TBL] [Abstract][Full Text] [Related]
28. Circulating serum exosomal
Lu X; Lu J; Wang S; Zhang Y; Ding Y; Shen X; Jing R; Ju S; Chen H; Cong H
Future Oncol; 2021 Mar; 17(8):907-919. PubMed ID: 33533649
[TBL] [Abstract][Full Text] [Related]
29. Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis.
Wilting SM; Verlaat W; Jaspers A; Makazaji NA; Agami R; Meijer CJ; Snijders PJ; Steenbergen RD
Epigenetics; 2013 Feb; 8(2):220-8. PubMed ID: 23324622
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of microRNA 92a Expression and Its Target Protein Bim in Colorectal Cancer.
Zaki A; Fawzy A; Akel SY; Gamal H; Elshimy RAA
Asian Pac J Cancer Prev; 2022 Feb; 23(2):723-730. PubMed ID: 35225486
[TBL] [Abstract][Full Text] [Related]
31. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
[TBL] [Abstract][Full Text] [Related]
32. Serum miR-638 Combined with Squamous Cell Carcinoma-Related Antigen as Potential Screening Biomarkers for Cervical Squamous Cell Carcinoma.
Zheng S; Li R; Liang J; Wen Z; Huang X; Du X; Dong S; Zhu K; Chen X; Liu D; Wu J; Liu Y; Zou X; Wang Y; Li J; Zeng F; Feng L; Yang G; Jing C
Genet Test Mol Biomarkers; 2020 Apr; 24(4):188-194. PubMed ID: 32216635
[No Abstract] [Full Text] [Related]
33. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].
Mathur SP; Mathur RS; Gray EA; Lane D; Underwood PG; Kohler M; Creasman WT
Gynecol Oncol; 2005 Sep; 98(3):467-83. PubMed ID: 15982726
[TBL] [Abstract][Full Text] [Related]
34. Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer.
Farzanehpour M; Mozhgani SH; Jalilvand S; Faghihloo E; Akhavan S; Salimi V; Azad TM
Virol J; 2019 Oct; 16(1):116. PubMed ID: 31590680
[TBL] [Abstract][Full Text] [Related]
35. Plasma Hsa-miR-92a-3p in correlation with lipocalin-2 is associated with sepsis-induced coagulopathy.
Wang Y; Wang H; Zhang C; Zhang C; Yang H; Gao R; Tong Z
BMC Infect Dis; 2020 Feb; 20(1):155. PubMed ID: 32075600
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Values of miR-21, miR-124, and M-CSF in Patients With Early Cervical Cancer.
Ruan F; Wang YF; Chai Y
Technol Cancer Res Treat; 2020; 19():1533033820914983. PubMed ID: 32356483
[TBL] [Abstract][Full Text] [Related]
37. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
38. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
39. Circulating microRNA-133, microRNA-17 and microRNA-25 in serum and its potential diagnostic value in gastric cancer.
ZiaSarabi P; Sorayayi S; Hesari A; Ghasemi F
J Cell Biochem; 2019 Aug; 120(8):12376-12381. PubMed ID: 30861177
[TBL] [Abstract][Full Text] [Related]
40. MiR-520f acts as a biomarker for the diagnosis of lung cancer.
Zhou Y; Shen S
Medicine (Baltimore); 2019 Jul; 98(30):e16546. PubMed ID: 31348274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
